CHENEY CHANG: Open Payments
NPI 1245483544 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,864 in 90 payments from 18 companies in 2025. Trend: 2023 $4,704 · 2024 $3,003 · 2025 $1,864
Food & beverage: $1,755Education: $110
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $364 |
| Janssen Biotech, Inc. | 16 | $299 |
| GENZYME CORPORATION | 7 | $220 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 10 | $199 |
| Novartis Pharmaceuticals Corporation | 8 | $174 |
| UCB, Inc. | 2 | $95 |
| Arcutis Biotherapeutics, Inc. | 5 | $95 |
| Incyte Corporation | 4 | $77 |
| PFIZER INC. | 4 | $75 |
| Amgen Inc. | 3 | $59 |
Products named: TREMFYA, DUPIXENT, RINVOQ, ILUMYA, SKYRIZI, COSENTYX, Bimzelx, Zoryve.
Industry payments across TX — which companies pay providers there.
